The role of standard and novel radiotherapy approaches in management of retroperitoneal sarcomas

L M Wiltink; M J Spalek; C Sangalli; R L Haas

doi:10.1016/j.ejso.2022.08.029

The role of standard and novel radiotherapy approaches in management of retroperitoneal sarcomas

Eur J Surg Oncol. 2023 Jun;49(6):1111-1114. doi: 10.1016/j.ejso.2022.08.029. Epub 2022 Aug 29.

Authors

L M Wiltink¹, M J Spalek², C Sangalli³, R L Haas⁴

Affiliations

¹ Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: [email protected].
² Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
³ Department of Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁴ Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

PMID: 36115783
DOI: 10.1016/j.ejso.2022.08.029

Abstract

Primary non-metastatic retroperitoneal soft tissue sarcoma patients can be cured by radical surgery. However there remains a risk for patients to develop a local recurrence. To minimize this risk, patients with low grade liposarcomas might benefit from preoperative radiotherapy. This review summarizes all issues that should be considered for the irradiation of patients with retroperitoneal soft tissue sarcoma.

Keywords: Delineation; Radiation therapy; Retroperitoneal sarcoma; Timing of radiotherapy.

Publication types

Review
Comment

MeSH terms

Humans
Liposarcoma* / radiotherapy
Liposarcoma* / surgery
Neoplasm Recurrence, Local / pathology
Radiotherapy Dosage
Radiotherapy, Adjuvant
Retroperitoneal Neoplasms* / pathology
Retroperitoneal Neoplasms* / radiotherapy
Retroperitoneal Neoplasms* / surgery
Sarcoma* / pathology
Sarcoma* / radiotherapy
Sarcoma* / surgery